| Investor Type | Firm |
| Type of Fund | Venture Capital Fund |
| Industries | Pharmaceutical (& Medicine) |
| Stages | Pre-seed, Seed |
| Investing | United States • Canada • Switzerland |
| Investment Range | $250,000 - $1,000,000 |
We are a regenerative medicine focussed fund backed by Panacea Venture. Our team, partners, and advisors are individually successful as investors, scientists, and entrepreneurs.
We are a regenerative medicine focussed fund backed by Panacea Venture. Our team, partners, and advisors are individually successful as investors, scientists, and entrepreneurs.
What we look for: We invest in early-stage companies emerging from leading academic labs and research institutions in the field of regenerative medicine. We focus on therapies and technologies that can repair, replace, or regenerate organs, tissues, cells, and/or genes with the goal of treating the root causes of disease, rather than managing symptoms.
How we help: We actively support our founders and portfolio companies at the early stage and help guide the team as needed. We take board seats and board observer roles.
